Table 3. Percentage of hypomethylation among common markers by cell type and sex.
Results are summarised for single cell-specific (CD19+B,CD4+T,CD8+T,CD56+NK,CD14+Mono,CD16+Neu) and multi- cell-specific (Myeloid, Pan T, Lymphocyte-I, Lymphocyte-II) marker panels.
| Sex | Single cell-specific markers | ||||||
|---|---|---|---|---|---|---|---|
| CD19+B | CD4+T | CD8+T | CD56+NK | CD14+Mono | CD16+Neu | ||
| Female | 58.24 | 65.57 | 35.99 | 90.19 | 94.71 | 96.39 | |
| Male | 58.24 | 65.57 | 35.99 | 90.19 | 94.71 | 96.39 | |
| Multi- cell-specific markers | |||||||
| Myeloid | Female | – | – | – | – | 93.53 | 93.41 |
| Male | – | – | – | – | 93.53 | 93.41 | |
| Pan T | Female | – | 43.30 | 43.30 | – | – | – |
| Male | – | 43.30 | 43.30 | – | – | – | |
| Lymphocyte-I | Female | 29.52 | 26.70 | 27.26 | 29.11 | – | – |
| Male | 29.52 | 26.70 | 27.46 | 28.86 | – | – | |
| Lymphocyte-II | Female | – | 44.13 | 45.56 | 45.72 | – | – |
| Male | – | 44.13 | 45.65 | 45.81 | – | – | |